Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue...
Drug safety advice
- Antipsychotics: risk of venous thromboembolic events
- Chloral hydrate (Welldorm) and Triclofos: not first-line options for insomnia
- Oral salicylate gels: not for use in those younger than age 16 years
- Topical ketoprofen: reminder on risk of photosensitivity reactions
Yellow Card scheme update
- The Black Triangle Scheme
Hot topic
- Counterfeit medicines: patient guidance for distribution via pharmacies
Stop press
- Clopidogrel and proton pump inhibitors: possible interaction
- Erlotinib: new safety information
- Counterfeit insulin pen Novofine needles: vigilance needed for lot number 08J02S
- Prescription of blood lancet devices: hepatitis risk from incorrect use
Other information from the MHRA
- Patient Information Leaflets of the month: Skelid for Paget’s disease
- Medical devices: practice guidance
Drug Safety Update: Volume 2 Issue 11, June 2009 
